# Dr. Mahmoud Abdelaal, MBBCh, PGD

> Dr. Mahmoud Abdelaal is a physician and medical affairs manager based in Abu Dhabi, United Arab Emirates. He has led medical affairs for rare disease, orphan drug and gene therapy portfolios across six Gulf markets, managed a team of six, launched three therapies and completed 118 modules of research ethics and good clinical practice training.

## Selected work
- [SPECTRIA](https://www.spectria.app/): 5 dimensions measured
- [Parlo Italiano](https://www.parlo-italiano.app/): 19 lessons, with 3D practice games
- [Mammography report classification](https://github.com/DrGM87/Mammography-Report-Classification-Competition): 14th of 371 teams, private leaderboard, top 4%
- [Harmonizing the Data of your Data](https://github.com/DrGM87/NCEMS---Harmonizing-the-Data-of-your-Data): 2 passes, extraction then verification
- [Echoes of Silenced Genes](https://github.com/DrGM87/Myllia-Challenge): 7th of 219 teams, public leaderboard 4.090

## Profile
- [Main profile](https://www.drmahmoudaza.com/): medical affairs manager in rare disease, orphan drugs and gene therapy across six Gulf markets, with three therapy launches and a 100+ KOL network.
- [What I do](https://www.drmahmoudaza.com/#capability): Medical affairs, Evidence and research, Launch and access, Governance and compliance, Leadership.
- [In numbers](https://www.drmahmoudaza.com/#numbers): 6 Gulf markets covered; 24 orphan and speciality products; 18 partner companies represented; 100+ KOL network across the Gulf and MENA; 34 KOLs at the Myalept launch conference; 3 congenital leptin deficiency patients on treatment.
- [Open to](https://www.drmahmoudaza.com/#open-to): Medical Affairs Manager and above, including Associate Director, Medical Director, Senior MSL and Medical Advisor roles.
- [Advisory boards and scientific exchange](https://www.drmahmoudaza.com/#advisory): advisory boards, symposia and expert input meetings across the Gulf.
- [Governance, compliance and medical review](https://www.drmahmoudaza.com/#governance): medical review, partner engagement governance and pharmacovigilance support.

## Launch and access record
- [Launch and access record](https://www.drmahmoudaza.com/#launch-record): Myalept, Givosiran, Ivacaftor and the cystic fibrosis portfolio, Endari, Translarna.

## Portfolio carried
- [Portfolio carried](https://www.drmahmoudaza.com/#portfolio): Eighteen partner companies and twenty four products across six therapy areas.
- Haematology and genetic disorders: Bluebirdbio, Global Blood Therapeutics, Emmaus Medical, Orchard Therapeutics, Mirum Pharmaceuticals
- Metabolic and neuromuscular: Alnylam, PTC Therapeutics, Green Cross, Lucane Pharma, Mitsubishi Tanabe, Etoro Pharma
- Nephrology and immunology: Calliditas Therapeutics, Aegerion, Veloxis
- Oncology: BeiGene, Incyte
- Respiratory: Vertex Pharmaceuticals
- Neonatology: BCO Pharma

## Experience
- [Medical affairs experience](https://www.drmahmoudaza.com/#experience): Regional Medical Affairs Manager, GCC (Rare Diseases), Taiba Pharma LLC (Dec 2018 to Dec 2020); Co-founder and Medical and Scientific Advisor (Contract), Cyntexia Pharma (Jan 2021 to Dec 2025); Medical Science Liaison, Dermatology, Local pharmaceutical company, Egypt (Nov 2016 to Nov 2018).

## Credentials
- [All 19 credentials with issuer and ID](https://www.drmahmoudaza.com/#credentials)
- CITI Program research ethics and GCP: 9 courses, 118 modules, June 2014.
- University of California San Diego drug development: 3 courses, 22 modules, 2021 to 2022.
- LearnQuest AI for scientific research: 4 courses, 2022.
- MBBCh, Faculty of Medicine, Benha University, and Postgraduate Diploma in Nutritional Medicine.

## Publications
- [Publications and presentations](https://www.drmahmoudaza.com/#publications): first author of an American Society of Hematology abstract in Blood 2020 and a Springer chapter 2015, contributing author on a Clinical Biomechanics paper with 47 citations.
- [Presentations at international congresses](https://www.drmahmoudaza.com/#presentations): five international congress presentations on frailty, wound healing and the diabetic foot.

## Markets and languages
- Gulf: Open to roles in the Gulf, in Italy and in France.
- Europe: France and Italy, where he holds work rights.
- Arabic Native, English Full professional, C1, Italian Elementary, A1, German Basic.

## Languages of this site
- English: https://www.drmahmoudaza.com/
- AR: https://www.drmahmoudaza.com/ar/
- FR: https://www.drmahmoudaza.com/fr/
- IT: https://www.drmahmoudaza.com/it/

## Contact
- LinkedIn: https://www.linkedin.com/in/drgm0/